Search
Patexia Research
Case number IPR2017-01168

Pfizer, Inc. v. Biogen, Inc. > Documents

Date Field Doc. No.PartyDescription
Jan 2, 2019 60 Patent Owner's Notice of Appeal Download
Oct 31, 2018 59 Termination Decision Document Download
Aug 9, 2018 58 Updated Mandatory Notice Download
Aug 6, 2018 57 Hearing Transcript Download
Aug 6, 2018 56 Hearing Transcript Download
Jul 16, 2018 55 Order - Trial Hearing - 37 CFR 42.70 Download
Jul 16, 2018 54 Decision - Granting Unopposed Motion for Pro Hac Vice Admission of Mr. Ryan P. Johnson - 37 CFR 42.10(c) Download
Jul 12, 2018 1040 EX1040 Ryan Johnson Declaration Download
Jul 12, 2018 52 Pet. Motion for Pro Hac Vice of Ryan P. Johnson Download
Jul 12, 2018 53 Pet. Updated Exhibit List (as of 7-12-2018) Download
Jul 10, 2018 51 Petitioner's Updated Mandatory Notice Download
Jul 10, 2018 50 Petitioner's Updated Power Of Attorney Appointing Additional Counsel Download
Jul 9, 2018 48 Petitioner's Reply To Opposition To Motion To Exclude Evidence Download
Jul 9, 2018 49 Patent Owner's Reply In Support of Motion to Exclude Evidence Download
Jun 29, 2018 47 Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence Download
Jun 29, 2018 46 Petitioner's Response To Patent Owner's Motion For Observations Download
Jun 29, 2018 45 Petitioner's Opposition To Patent Owner¿¿¿s Motion To Exclude Evidence Download
Jun 22, 2018 42 Patent Owner's Motion to Exclude Evidence Download
Jun 22, 2018 2020 Ex 2020 Soiffer Depo Transcript Download
Jun 22, 2018 2015 Ex 2015 Freedman Publication Download
Jun 22, 2018 2014 Ex 2014 Lilford Publication Download
Jun 22, 2018 41 Patent Owner's Motion for Observations on Cross Examination Download
Jun 22, 2018 2018 Ex 2018 Koreth Publication Download
Jun 22, 2018 2017 Ex 2017 Soiffer Publication Download
Jun 22, 2018 43 Patent Owner's Request for Oral Argument Download
Jun 22, 2018 1039 Ex. 1039 - Freedman et al., "Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Dose Intensification with Granulocyte Colony-Stimulating Factor..." Blood, 90(12):4996-5001 (1997) Download
Jun 22, 2018 44 Patent Owner's Updated Exhibit List Download
Jun 22, 2018 2013 Ex 2013 Cook Publication Download
Jun 22, 2018 2016 Ex 2016 Petitioner's Reply to Patent Owner's Response (IPR2017-01168) Download
Jun 22, 2018 39 Petitioner's Request For Oral Hearing Download
Jun 22, 2018 38 Petitioner's Motion To Exclude Evidence Download
Jun 22, 2018 40 Petitioner's Updated Exhibit List (As Of June 22, 2018) Download
Jun 22, 2018 2019 Ex 2019 Fisher Publication Download
Jun 21, 2018 37 Petitioner's Objections To Exhibits Download
Jun 5, 2018 36 Petitioner's Updated Mandatory Notice Download
Jun 4, 2018 35 Granting Petitioner¿¿¿s Motion to Withdraw Counsel 37 C.F.R. sec. 42.5, 42.10(e) Download
Jun 1, 2018 33 Notice Of Joint Stipulation To Modify Due Dates 4-5 Download
Jun 1, 2018 34 Notice of Deposition of Robert J. Soiffer, M.D. Download
May 31, 2018 32 Petitioner's Unopposed Motion For Counsel To Withdraw Download
May 30, 2018 31 Patent Owner's Objections to Evidence Download
May 24, 2018 1037 Ex. 1037 - Vose et al., "Phase II Study of Rituximab in Combination with CHOP Chemotherapy in Patients with Previously Untreated, Aggressive Non-Hodgkin¿¿¿s Lymphoma," J. Clin. Oncol., 19:389-397 (2001) ("Vose") Download
May 24, 2018 1035 Ex. 1035 - Declaration of Robert J. Soiffer, M.D. in support of Petitioner's Reply to Patent Owner's Response Download
May 24, 2018 30 Petitioner's Updated Exhibit List (As of May 24, 2018) Download
May 24, 2018 1038 Ex. 1038 - Freedman et al., "Autologous Bone Marrow Transplantation in Poor-Prognosis Intermediate-Grade and High-Grade B-cell non-Hodgkin's Lymphomas in First Remission: A Pilot Study," J. Clin. Oncol., 11(5):931-936 (1993) ("Freedman") Download
May 24, 2018 1033 Ex. 1033 - McCoy et al., "A Novel Preparing Regimen for Autologous Transplant in Non-Hodgkin's Lymphomas: Long-Term Experience with Etoposide and Thiotepa," Bone Marrow Transplantation, 33:19-24 (2004) (as presented during Dr. Kahl deposition) ("Kahl") Download
May 24, 2018 29 Petitioner's Reply To Patent Owner's Response Download
May 24, 2018 1034 Ex. 1034 - Deposition Transcript of Brad S. Kahl, M.D., taken on April 14, 2018 Download
May 24, 2018 1036 Ex. 1036 - Coiffier et al., "CHOP Chemotherapy Plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large B Cell Lymphoma," N.E. J. Med., 346:235-242 (2002) ("Coiffier 2022") Download
Apr 10, 2018 28 Decision - Granting Unopposed Motion for Pro Hac Vice Admission of Mr. David Gindler - 37 CFR 42.10(c) Download
Mar 30, 2018 27 Notice Of Deposition Of Brad S. Kahl, M.D. Download
Mar 5, 2018 26 Petitioner¿¿¿s Objections To Exhibits Download
Feb 26, 2018 2004 Ex 2004 Gribben, Effectiveness of High-Dose Combination Chemotherapy & Autologous Bone Marrow Transplantation Download
Feb 26, 2018 2002 Ex 2002 IPR2017-01168 Petition Download
Feb 26, 2018 2006 Ex 2006 Haioun, Benefit of Autologous Bone Marrow Transplantation Download
Feb 26, 2018 2007 Ex 2007 Goss, Non-Hodgkin's Lymphomas in Elderly Patients Download
Feb 26, 2018 24 Patent Owner Response Download
Feb 26, 2018 2010 Ex 2010 Armitage, Treatment of Non-Hodgkin's Lymphoma Download
Feb 26, 2018 2003 Ex 2003 "What is a Stem Cell Transplant," Cancer.net, Jan. 2016 Download
Feb 26, 2018 2008 Ex 2008 Ozer Depo Transcript Download
Feb 26, 2018 2012 Ex 2012 Song Declaration Download
Feb 26, 2018 25 Patent Owner's Updated Exhibit List Download
Feb 26, 2018 2005 Ex 2005 Philip, High-Dose Therapy and Autologous Bone Marrow Transplantation Download
Feb 26, 2018 2009 Ex 2009 Kahl CV Download
Feb 26, 2018 2011 Ex 2011 Kahl Declaration Download
Feb 22, 2018 23 Joint Stipulation to Modify Due Date 1 Download
Feb 14, 2018 22 Motion to Appear Pro Hac Vice (Gindler) Download
Feb 14, 2018 2001 Ex 2001 Gindler PHV Declaration Download
Jan 31, 2018 21 Petitioner's Updated Mandatory Notice Download
Jan 26, 2018 20 Notice of Deposition of Howard Ozer Download
Jan 11, 2018 19 Granting Unopposed Motions for Pro Hac Vice Admissions Download
Jan 10, 2018 18 PETITIONER's UPDATED EXHIBIT LIST (AS OF JANUARY 10, 2018) Download
Jan 10, 2018 1031 Ex. 1031 - Declaration of Ilan Wurman Download
Jan 10, 2018 1032 Ex. 1032 - Declaration of Matthew J. Mezger Download
Jan 10, 2018 17 PETITIONER'S UNOPPOSED MOTION FOR PRO HAC VICE ADMISSION OF ILAN WURMAN AND MATTHEW J. MEZGER Download
Dec 27, 2017 16 Patent Owner's Updated Mandatory Notice Download
Dec 21, 2017 15 Notice of Joint Stipulation to Modify Due Dates 1-2 Download
Dec 19, 2017 14 PETITIONER'S UPDATED MANDATORY NOTICE Download
Dec 19, 2017 13 PETITIONER'S UPDATED POWER OF ATTORNEY Download
Dec 5, 2017 12 Petitioner's Updated List of Exhibits (as of December 5 2017) Download
Dec 5, 2017 11 PETITIONER'S SERVICE OF SUPPLEMENTAL EVIDENCE Download
Nov 20, 2017 9 Petitioner's Updated Exhibit List (as of 11-20-2017) Download
Nov 20, 2017 8 Petitioner's Unopposed Motion for PHV Admission of Charles B. Klein and Eimeric Reig-Plessis Download
Nov 20, 2017 1026 Ex. 1026 - Declaration of Eimeric Reig-Plessis ISO PHV Motion Download
Nov 20, 2017 1025 Ex. 1025 - Declaration of Charles B. Klein ISO PHV Motion Download
Nov 20, 2017 10 Patent Owner's Objections to Exhibits Download
Nov 6, 2017 7 Scheduling Order Download
Nov 6, 2017 6 Trial Instituted Document Download
May 18, 2017 4 Power of Attorney Download
May 18, 2017 5 Patent Owner's Mandatory Notice Download
May 8, 2017 3 Notice of Accord Filing Date Download
Apr 28, 2017 1019 Ex. 1019 - U.S. Application No. 14/045,375, Non-Final Office Action (dated Jan. 6, 2014) Download
Apr 28, 2017 1013 Ex. 1013 - Kenneth A. Foon & Richard I. Fisher, "Lymphomas," Hematology, 5th Ed. (1995), 1076-1096 ("Foon") Download
Apr 28, 2017 1024 Ex. 1024 - U.S. Application No. 14/045,375, Utility Patent Application Transmittal (dated Oct. 3, 2013) Download
Apr 28, 2017 1017 Ex. 1017 - Michael L. Grossbard et al., "Monoclonal Antibody-Based Therapies of Leukemia and Lymphoma," Blood, 80(4):863-878 (1992) ("Grossbard") Download
Apr 28, 2017 1022 Ex. 1022 - Tsai et al., "Progressive Intermediate Grade Non-Hodgkin's Lymphoma After High Dose Therapy," Blood, 92(10 Suppl. 1):415a (1998) ("Tsai") Download
Apr 28, 2017 1021 Ex. 1021 - U.S. Application No. 14/045,375, Notice of Allowability (dated Mar. 25, 2014) Download
Apr 28, 2017 2 PETITION FOR INTER PARTES REVIEW Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 5 Download
Apr 28, 2017 1023 Ex. 1023 - Physicians' Desk Reference (53rd ed. 1999) (excerpted), "Rituxan (Rituximab)" Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 5 Download
Apr 28, 2017 1018 Ex. 1018 - James O. Armitage et al., "Bone Marrow Transplantation," Clinical Oncology, Abeloff et al., Eds. (1995), 295-305 ("Armitage I") Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 5 Download
Apr 28, 2017 1011 Ex. 1011 - W. Hiddemann, "Non-Hodgkin's Lymphoma - Current Status of Therapy and Future Perspectives," Eur. J. Cancer, 31A:2141-2145 (1995) ("Hiddemann II") Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 5 Download
Apr 28, 2017 1015 Ex. 1015 - Arthur T. Skarin & David M. Dorfman, "Non-Hodgkin's Lymphomas: Current Classification and Management," CA Cancer J. Clinicians, 47(6):351-372 (1997) ("Skarin") Download
Apr 28, 2017 1012 Ex. 1012 - Hiddemann et al. "Lymphoma Classification - The Gap Between Biology and Clinical Management is Closing," Blood, 88(11):4085-4089 (1996) ("Hiddemann III") Download
Apr 28, 2017 1020 Ex. 1020 - U.S. Application No. 14/045,375, Amendment and Response to Non-Final Office Action (dated Feb. 14, 2014) Download
Apr 28, 2017 1014 Ex. 1014 - Michael J. Campbell & John E. Niederhuber, "B-Lymphocyte Responses," Clinical Oncology, Abeloff et al., Eds. (1995), 100-126 ("Campbell") Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 5 Download
Apr 28, 2017 1007 Ex. 1007 - Moreau et al., "Peripheral Blood Stem Cell Transplantation as Front-line Therapy in Patients Aged 61 to 65 Years: A Pilot Study," Bone Marrow Transplantation, 21:1193-1196 (1998) ("Moreau") Download
Apr 28, 2017 1003 Ex. 1003 - Caroline McNeil, "Non-Hodgkin's Lymphoma Trials In Elderly Look Beyond CHOP," J. Nat'l Cancer Inst., 90(4):266-67 (Feb. 18, 1998) ("McNeil") Download
Apr 28, 2017 1009 Ex. 1009 - Shipp et al., "High-Dose CHOP as Initial Therapy for Patients with Poor-Prognosis Aggressive Non-Hodgkin's Lymphoma: A Dose-Finding Pilot Study," J. Clin. Oncol., 13(12):2916-2923 (1995) ("Shipp") Download
Apr 28, 2017 1002 Ex. 1002 - Declaration of Ozer, M.D., Ph.D. Download
Apr 28, 2017 1004 Ex. 1004 - Rituxan (rituximab) labeling (Nov. 1997) ("Rituxan label") Download
Apr 28, 2017 1006 Ex. 1006 - Coiffier et al., "Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients with Relapsing or Refractory Aggressive Lymphoma: 92(6):1927-1932 (1998) ("Coiffier") Download
Apr 28, 2017 1005 Ex. 1005 - Link et al., Phase II Pilot Study of the Safety and Efficacy of Rituximab , Thirty-Fourth Annual Meeting, (May 1998) ("Link") Download
Apr 28, 2017 1008 Ex. 1008 - Maloney et al., "IDEC-C2B8: Results of a Phase I Multiple-Dose Trial in Patients with Relapsed Non-Hodgkin's Lymphoma," J. Clin. Oncol., 15(10):3266-3274 (1997) ("Maloney") Download
Apr 28, 2017 1 Petitioner's Power of Attorney Download
Apr 28, 2017 1010 Ex. 1010 - Martelli et al., "Current Guidelines for the Management of Aggressive Non-Hodgkin's Lymphoma," Drugs, 53(6):957-972 (1997) ("Martelli") Download
Apr 28, 2017 1001 Ex. 1001 - White et al., U.S. Patent No. 8,821,873 B2 Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 4 Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 2 Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 3 Download
Apr 28, 2017 1016 Ex. 1016 - Declaration of Scott Bennett, Ph.D.-Part 1 Download
Menu